ScinoPharm Taiwan Ltd (1789) — Cash Flow Reinvestment Rate
ScinoPharm Taiwan Ltd (1789) has a Cash Flow Reinvestment Rate of 0.42x as of March 2026, reinvesting NT$83.34 Million (capex NT$83.34 Million ) from operating cash flow of NT$199.47 Million. See ScinoPharm Taiwan Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ScinoPharm Taiwan Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for ScinoPharm Taiwan Ltd across 19 annual periods. For the full cash flow conversion analysis, see how efficiently does ScinoPharm Taiwan Ltd generate cash.
Annual Cash Flow Reinvestment Rate for ScinoPharm Taiwan Ltd (2007–2025)
Year-by-year capital reinvestment analysis for ScinoPharm Taiwan Ltd. See ScinoPharm Taiwan Ltd (1789) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.42x | NT$1.45 Billion | NT$597.11 Million | NT$291.29 Million | ▲ +529.6% |
| 2024 | 0.38x | NT$288.73 Million | NT$750.91 Million | NT$288.73 Million | ▼ -82.8% |
| 2023 | 2.24x | NT$518.00 Million | NT$231.13 Million | NT$284.71 Million | ▲ +244.3% |
| 2022 | 0.65x | NT$503.66 Million | NT$773.79 Million | NT$250.04 Million | ▼ -43.1% |
| 2021 | 1.14x | NT$582.83 Million | NT$509.82 Million | NT$321.32 Million | ▲ +69.6% |
| 2020 | 0.67x | NT$637.86 Million | NT$946.31 Million | NT$183.10 Million | ▲ +354.8% |
| 2019 | 0.15x | NT$116.94 Million | NT$788.95 Million | NT$105.70 Million | ▼ -39.6% |
| 2018 | 0.25x | NT$302.37 Million | NT$1.23 Billion | NT$127.05 Million | ▼ -45.5% |
| 2017 | 0.45x | NT$437.94 Million | NT$971.71 Million | NT$410.93 Million | ▲ +13.6% |
| 2016 | 0.40x | NT$660.84 Million | NT$1.67 Billion | NT$458.52 Million | ▼ -56.4% |
| 2015 | 0.91x | NT$951.79 Million | NT$1.04 Billion | NT$667.58 Million | ▼ -38.1% |
| 2014 | 1.47x | NT$1.31 Billion | NT$888.29 Million | NT$1.02 Billion | ▲ +2.3% |
| 2013 | 1.44x | NT$1.35 Billion | NT$939.47 Million | NT$1.24 Billion | ▲ +60.3% |
| 2012 | 0.90x | NT$881.19 Million | NT$981.55 Million | NT$881.19 Million | ▲ +43.4% |
| 2011 | 0.63x | NT$810.14 Million | NT$1.29 Billion | NT$810.14 Million | ▲ +141.4% |
| 2010 | 0.26x | NT$405.62 Million | NT$1.56 Billion | NT$405.62 Million | ▲ +75.9% |
| 2009 | 0.15x | NT$191.28 Million | NT$1.30 Billion | NT$191.28 Million | ▲ +43.4% |
| 2008 | 0.10x | NT$144.62 Million | NT$1.41 Billion | NT$144.62 Million | ▼ -37.3% |
| 2007 | 0.16x | NT$82.74 Million | NT$504.50 Million | NT$82.74 Million | — |